|
|
|
Insider
Information: |
Bolzon Bradley J Phd |
Relationship: |
Director, 10% Owner |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
21,851 |
|
Indirect Shares
|
13,354,534 |
|
|
Direct
Value |
$96,363 |
|
|
Indirect Value
|
$77,179,337 |
|
|
Total
Shares |
13,376,385 |
|
|
Total
Value |
$77,275,700 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
Director, 10% Owner |
|
0 |
2014-02-18 |
3,206,807 |
Premium* |
|
Phaserx, Inc. |
PZRX |
10% Owner |
|
0 |
2016-05-23 |
1,931,094 |
Premium* |
|
Crispr Therapeutics Ag |
CRSP |
Director |
2021-06-29 |
0 |
2021-07-19 |
498,558 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
Director, 10% Owner |
2020-12-14 |
21,851 |
2020-12-14 |
5,606,424 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
Director, 10% Owner |
2021-06-28 |
0 |
2021-06-28 |
2,097,938 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
134 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-01 |
4 |
S |
$91.27 |
$5,550,644 |
I/I |
(60,000) |
0 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-01 |
4 |
OE |
$13.62 |
$1,513,950 |
I/I |
60,000 |
60,000 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
42,272 |
42,272 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-09 |
4 |
AS |
$0.00 |
$0 |
I/I |
(207,408) |
0 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,391 |
7,391 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-10 |
4 |
AS |
$85.03 |
$1,949,996 |
I/I |
(22,845) |
531,345 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-14 |
4 |
AS |
$84.89 |
$98,045 |
I/I |
(1,155) |
530,190 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-16 |
4 |
AS |
$86.98 |
$779,777 |
I/I |
(8,965) |
521,225 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
8,707 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-09-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(750,612) |
0 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
21,396 |
4,131 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-18 |
4 |
AS |
$86.87 |
$263,636 |
I/I |
(3,035) |
518,190 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
84,544 |
84,544 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-22 |
4 |
AS |
$0.00 |
$0 |
I/I |
(414,816) |
10,355 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
14,780 |
22,171 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-06 |
4 |
AS |
$33.26 |
$601,654 |
I/I |
(18,090) |
5,781,250 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,471 |
10,178 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-07 |
4 |
AS |
$0.00 |
$0 |
I/I |
(294,920) |
0 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
5,312 |
4,131 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-07 |
4 |
AS |
$33.56 |
$934,079 |
I/I |
(27,836) |
5,756,660 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-08 |
4 |
AS |
$33.25 |
$616,748 |
I/I |
(18,425) |
5,740,384 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-09 |
4 |
AS |
$33.67 |
$127,933 |
I/I |
(3,800) |
5,737,027 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-12 |
4 |
AS |
$33.11 |
$13,243 |
I/I |
(400) |
5,736,674 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-13 |
4 |
AS |
$33.39 |
$391,984 |
I/I |
(11,739) |
5,726,304 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-14 |
4 |
AS |
$33.09 |
$182,031 |
I/I |
(5,501) |
5,721,445 |
0 |
- |
|
134 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|